MNAC13

MNAC13 is a kind of mouse IgG1 chimeric antibody, targeting to human TrkA. MNAC13 inhibits the NGF dependent signaling pathway by specifically binding to TrkA receptors. MNAC13 has good analgesic effect and long-lasting efficacy. MNAC13 can be used for researches on inflammatory and chronic pain[1][2].

12352203

Trk Receptor

Neuronal Signaling; Protein Tyrosine Kinase/RTK

COVID-19-immunoregulation

Inflammation/Immunology; Neurological Disease

[1]Ugolini G, et al. The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain. Proc Natl Acad Sci U S A. 2007 Feb 20;104 (8) :2985-90. |[2]Cattaneo A, et al. Functional blockade of tyrosine kinase A in the rat basal forebrain by a novel antagonistic anti-receptor monoclonal antibody. J Neurosci. 1999 Nov 15;19 (22) :9687-97.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-P991622/

Inhibitory Antibodies

No Development Reported

TrkA